Advertisement

Topics

BRIEF—$20.5 million for EIP Pharma to develop Alzheimer's candidate

10:53 EDT 17 May 2018 | thePharmaLetter

CNS disease specialist EIP Pharma has raised $20.5 million in a series B financing round led by Access…

Original Article: BRIEF—$20.5 million for EIP Pharma to develop Alzheimer's candidate

NEXT ARTICLE

More From BioPortfolio on "BRIEF—$20.5 million for EIP Pharma to develop Alzheimer's candidate"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...